Description: Explore cutting-edge advancements in virtual care, including remote patient monitoring and care delivery in the metaverse, which build on the foundation that pandemic-era telehealth built. Gain a deep understanding of how these innovations are set to shape the future of telehealth and healthcare more broadly. By attending the session, you will be equipped with a roadmap of the key trends and opportunities in virtual care, and be able to identify potential challenges and solutions for their own organizations in leveraging these new tools.

Description: Government credit programs are intended to meet various social and economic objectives. By providing more favorable terms than are available from private lenders, credit programs assist borrowers, including some who could not obtain funds otherwise. From Study of Public Financial Guarantee Programs, M-FI96-2.

Description: This interactive session provides an introduction to behavioral economics, including groups identifying areas where behavioral economics could be applied in actuarial practice. Experience a practical application workshop using behavioral economics for direct sale products. Break out into small groups and develop an outline of a BE based sales program for a product of your choosing to be sold over the internet. Gain feedback and take part in a discussion. By attending the session, you will: - Understand the basic concepts of behavioral economics. - Have some ideas of how it can be applied to actuarial practice. - Learn how to design a product using BE and how to design an experiment to test the effectiveness of an application of BE.

Description: This is an Excel workbook, provided by the Society of Actuaries Pension Section, containing consumer price index data obtained from the U.S. Department of Labor Bureau of Labor Statistics. Separate tabs include figures for the CPI-U, the Medical Care Consumer Price Index, etc.

Description: This report helps to identify key socioeconomic trends influencing the need and demand for the industry's products and services, and how these trends will influence marketing methods.

Description: The Study was designed to elicit reasons behind the participants’ judgments about the future course of the four variables. In the first round participants were asked to provide judgments about the value of the four variables in 2024 and the reasons behind their judgments. The four variables were 1. Increase in CPI, 2. 10 Year Treasury Yield, 3. S&P500 Total Rate of Return, and 4.Corporate Baa yield. In addition, they were asked to list future developments that could cause historical trends in the variables to change. Finally they were asked to express their views on how the judgmental process employed in this study might influence the use and interpretation of traditional actuarial e.g., stochastic, deterministic estimation processes or to aid in planning. The data were collated between rounds and in the second Round, the responses of the group were provided to the participants.

Description: Many drugs, like the immunologic drugs used to treat inflammatory and oncologic conditions, are FDA-authorized to treat more than one condition. Given different conditions have varying clinical outcomes and costs, it is likely the same drug provides a range of value across multiple conditions. However, such drugs have traditionally had a single list price and corresponding payer net cost. Indication-based pricing and benefit design (IBPBD) is intended to address the variable clinical and economic value for the same drug across multiple treatment indications. As this trend continues to evolve, the determination of drug value by treatment indication will create risks and/or opportunities in pharmacy benefit design, ultimately impacting pharmacy PMPM forecasting and incurred costs. Learn from faculty as they: Provide the business context for IBPBD. Describe varying structural approaches. Discuss the market conditions that can motivate or demotivate payers. Explore operational barriers. Recommend a role for actuaries. To bring the discussion to life, a case study will be reviewed. By attending the session, you will be able to: • Describe the meaning of Indication-Based Drug Pricing and Benefit Design (IDPBD). • Understand the risks and opportunities with IBPBD. • Articulate the advantages and disadvantages of distinguishing the value of a drug by treatment indications.

Description: Appendix B is round 2 questionnaire on the study of selected economic variables using the Delphi method from the Delphi Report. See the SOA website Research for the complete report of the Delphi Study of Economic Variables Report which includes all the appendices.

Description: Appendix F is round 1 future developments from the Delphi report. Please see the SOA website Research section for the full Delphi Study of Economic Variables Report along with all of the appendices.

Description: Fully remote and hybrid environments are here to stay and actuarial leaders are continuing to evolve their styles and strategies to accommodate shifting needs. In order to build engaged and future-focused teams, leaders must refine their management approach and be intentional about helping employees build relationships, connect to culture, and lean into their futures with the organization. Listen as the panel shares their insights and experiences on how they have built loyalty and increased productivity among staff to meet business goals and move forward in the new working environment. By attending this session, you will be able to: • Understand the state of the actuarial talent market and changing employee expectations, and what it may mean for your department. • Identify how to best support and engage your employees in a remote and/or hybrid work model. • Apply strategies to enhance communication, lead with empathy and build trust among your team. • Empower and energize your team to increase retention and overall productivity.